Market revenue in 2023 | USD 41.1 million |
Market revenue in 2030 | USD 51.4 million |
Growth rate | 3.2% (CAGR from 2023 to 2030) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | Freestyle Lite |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 20.44% in 2023. Horizon Databook has segmented the Mexico point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
The POC testing solutions in Mexican Association of Clinical Laboratory Sciences (CMCLC) are witnessing various improvements in terms of adoption and awareness. Self-monitoring devices and emergency departments have been witnessing greater demand in recent years, which offers lucrative growth opportunities to POC glucose testing product manufacturers in the country.
However, main barriers to market entry include higher cost of POC testing devices, restrictive government policies & their implementation, and higher adoption of sophisticated POC testing devices across intensive care units in comparison with other medical settings.
In spite of increasing adoption of POC devices in emergency units, lack of collaborative authorities that can aid in improving quality of management is expected to hinder the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account